
Anthony Albanese, Peter Dutton urged to adopt new funding model to offer lifesaving cancer drugs
April 22, 2025
Qld man John Mylne forked out $60,000 for a lifesaving cancer treatment…
Read more arrow_forwardQld man John Mylne forked out $60,000 for a lifesaving cancer treatment…
Read more arrow_forwardArticle from MedNews, By Megan Brodie 9 April 2025 After years of…
Read more arrow_forwardDespite decades of research and hundreds of billions of dollars dedicated to the search for cures, cancer is still the world’s biggest killer, responsible for the deaths of hundreds of thousands of people every year, 50,000 of them in Australia.
Read more arrow_forwardRare Cancers Australia (RCA), and Australia’s leading cancer experts, launch blueprint for…
Read more arrow_forwardRare Cancers Australia (RCA) co-founder and dedicated patient advocate, Ms Kate Vines, was honoured today for her contribution to the cancer sector, receiving the 2024 Jeannie Ferris Award.
Read more arrow_forwardRare Cancers Australia, and an army of peak cancer organisations, call on the Pharmaceutical Benefits Advisory Committee (PBAC) to expand access to the breakthrough PD-1/PD-L1 inhibitor class of medicines for the more than 3,500 Aussies who would benefit.
Read more arrow_forwardRare Cancers Australia (RCA) wishes to announce that Richard Vines will step down from his role as Chief Executive, effective 31 December 2023. Ms Christine Cockburn will assume the role as Chief Executive effective 1 January 2024.
Read more arrow_forwardAt Rare Cancers Australia, we believe the value of a treatment needs to look beyond the dollars on the price tag.
Read more arrow_forwardRosie May Fisher can’t remember when she first noticed a pea-sized lump…
Read more arrow_forwardOpinion Piece by Richard Vines, Published in The Australian, April 2023 Did…
Read more arrow_forward